SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

Glanbia shrugs off Dairy Ireland hit to post hot results

By Rod Addy+

12-Mar-2014
Last updated on 12-Mar-2014 at 14:08 GMT2014-03-12T14:08:30Z

Talbot: 'We expect 2014 to be another positive year'
Talbot: 'We expect 2014 to be another positive year'

Glanbia has boasted powerful growth in 2013 sales and profit, despite struggles in its Dairy Ireland and Ingredients Technologies businesses and squeezed margins.

The dairy products and ingredients giant outlined robust sales increases in its Global Performance Nutrition and Global Ingredients divisions against a backdrop of significant group investment. It is targeting 8–10% organic profit growth to 2018 with a strong focus on the sports nutrition market.

Global Performance Nutrition drove the bulk of the company’s success last year, it said, delivering 20% branded revenue growth and making headway in the US despite fierce competition.

The firm boosted profitability of the division by 28%, with speciality and internet sports nutrition markets proving especially buoyant. Its acquisition of Scandinavian sports nutrition business Nutramino in January would add fresh momentum to the unit, Glanbia added.

Record high costs

However, profit at its Dairy Ireland unit plunged, driven by the underperformance of its consumer products segment. This had been hit hard by record high costs for Irish milk and retailers’ resistance to translating those into price increases. Branded sales also performed weakly relative to own-label.

That said, annual value sales for Dairy Ireland still achieved low single digit increases and agribusiness sales delivered “a solid performance”, it stated. It plans to cut costs by redesigning its supply network and restructuring head office functions.

Plans are also underway for a €15M (£12.5M) ultra-high-temperature (UHT) processing facility at Wealso, Ireland, for long-life liquid milk and cream suitable for exporting to regions such as China, Europe and the Middle East. It expects the plant to be operational in the second financial quarter of this year.

In addition, Glanbia reported market prices for dairy-related products in its Ingredients Technologies business declined because of increased supply of core ingredients such as lactose and whey. That dragged down pre-tax profit for the division, despite demand remaining firm and sales volumes rising.

Expanded production

However, the company expected the development of speciality grains and expanded production of lactoferrin and dairy calcium to have a positive effect this year.

The group declared pre-tax profit up 9.2% for the year to January 4, 2014, from €214.6M (£179.4M) to €226.7M (£189.5M), on 10.5% group revenue growth.

“We expect 2014 to be another positive year for the group,” said recently appointed group md Siobhán Talbot, previously group finance director.

“We will benefit from our ongoing organic investment programme, good prospects for Global Ingredients and Global Performance Nutrition and an expected improvement in Dairy Ireland.

“Our ambition is to continue to deliver a similar annual organic growth rate through to 2018, while seeking to sustain a return on capital employed in excess of 12%.”

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars

Promotional Features